Global Touch Activated Phlebotomy Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Touch Activated Phlebotomy Device market size was valued at US$ 256 million in 2025 and is forecast to a readjusted size of US$ 587 million by 2032 with a CAGR of 12.1% during review period.
Touch Activated Phlebotomy Device refers to a venous blood collection device engineered around touch-triggered, often one-hand activation. It typically integrates needle protection, puncture activation, blood return indication/feedback, hemostasis support, and safety lockout in a single system to reduce procedural steps while improving consistency and safety. The device can be configured for vacuum tube collection, butterfly sets/extension tubing, or dedicated connector interfaces, serving routine laboratory phlebotomy and selected bedside sampling workflows. Its core value lies in touch-activated mechanics and closed or semi-closed fluid pathways that minimize exposed needle time and blood splashes, lowering needlestick risk, improving patient comfort, and enabling more standardized, efficient, and compliant phlebotomy operations.In 2025, global Touch Activated Phlebotomy Deviceproduction reached approximately 24.9 million units and price is about 10 usd/unit.The average gross profit margin of this product is 55%.
As healthcare providers strengthen occupational exposure prevention, infection control, and procedural standardization, safety upgrades in phlebotomy have become a firm requirement. Touch-activated phlebotomy devices align with the need to reduce steps, minimize exposure, and improve consistency—especially in high-throughput settings such as emergency departments, outpatient draw stations, and centralized pre-analytical workflows. Workforce shifts and rising training costs further favor intuitive, repeatable devices that reduce dependence on individual technique. In many institutions, “safe phlebotomy” is evolving into a system-level procurement and governance theme, driving upgrades from single consumables toward integrated offerings that combine devices, compatible disposables, and service—expanding the commercial runway for suppliers with interface ecosystems and scalable delivery capabilities.
Challenges center on clinical adaptability, cost sensitivity, and compliance validation. Venous variability, insertion angle, and activation force can influence first-stick success and patient experience; the device must deliver stable performance across patient populations and departments. Any issues such as insensitive triggering, unclear blood return feedback, or connector incompatibility can increase procedure time and complaints. Phlebotomy supplies are also high-frequency and cost-sensitive, so suppliers must balance safety upgrades with tight cost control and reliable supply. In addition, products incorporating needle safety mechanisms require robust quality systems, regulatory compliance, and real-world usability validation; inadequate training or inconsistent use can blunt the intended safety benefits and undermine repurchase and adoption within the hospital.
Demand is shifting from “usable” to “controllable, traceable, and standardized.” Providers increasingly focus on the entire pre-analytical quality chain—patient identification, collection consistency, hemolysis/clotting control, sample logistics efficiency, and documentation of occupational exposure events. Therefore, touch-activated devices must not only be safe and easy to use, but also fit seamlessly into vacuum tube systems, phlebotomy carts, and specimen management workflows. Health-check centers and IVD-related service settings emphasize throughput and low error rates, favoring solutions that shorten cycle time and reduce rework. For populations with difficult venous access (pediatrics, geriatrics, oncology), the market leans toward variants with enhanced control and clear visual/functional feedback. Overall, product portfolios are evolving toward scenario-specific series and a complementary consumable ecosystem.
Key upstream inputs include medical-grade stainless-steel cannulae and bevel grinding, medical polymers for hubs/housings and activation structures, elastomers and seals for valves and leak prevention, transparent materials for observation windows, and connector components compatible with vacuum tubes or extension sets. For safety lockout and anti-rebound mechanisms, consistency of micro-springs, latches, and precision assembly determines activation feel and reliability. Because the device contacts blood directly or operates in near-blood environments, biocompatibility, sterilization compatibility, extractables/leachables control, and batch stability are critical. At scale, injection mold accuracy, automated assembly yield, and in-line inspection capabilities become decisive. Ultimately, upstream stability and quality management translate into first-stick performance, leakage risk, and safety-mechanism reliability—forming the foundation for brand trust and long-term institutional partnerships.
This report is a detailed and comprehensive analysis for global Touch Activated Phlebotomy Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Touch Activated Phlebotomy Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Touch Activated Phlebotomy Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Touch Activated Phlebotomy Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Touch Activated Phlebotomy Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Touch Activated Phlebotomy Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Touch Activated Phlebotomy Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Greiner Bio-One, Terumo, Nipro, B. Braun, Sarstedt, Cardinal Health, Medline, ICU Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Touch Activated Phlebotomy Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Touch Activated Phlebotomy Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Touch Activated Phlebotomy Device, with price, sales quantity, revenue, and global market share of Touch Activated Phlebotomy Device from 2021 to 2026.
Chapter 3, the Touch Activated Phlebotomy Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Touch Activated Phlebotomy Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Touch Activated Phlebotomy Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Touch Activated Phlebotomy Device.
Chapter 14 and 15, to describe Touch Activated Phlebotomy Device sales channel, distributors, customers, research findings and conclusion.
Touch Activated Phlebotomy Device refers to a venous blood collection device engineered around touch-triggered, often one-hand activation. It typically integrates needle protection, puncture activation, blood return indication/feedback, hemostasis support, and safety lockout in a single system to reduce procedural steps while improving consistency and safety. The device can be configured for vacuum tube collection, butterfly sets/extension tubing, or dedicated connector interfaces, serving routine laboratory phlebotomy and selected bedside sampling workflows. Its core value lies in touch-activated mechanics and closed or semi-closed fluid pathways that minimize exposed needle time and blood splashes, lowering needlestick risk, improving patient comfort, and enabling more standardized, efficient, and compliant phlebotomy operations.In 2025, global Touch Activated Phlebotomy Deviceproduction reached approximately 24.9 million units and price is about 10 usd/unit.The average gross profit margin of this product is 55%.
As healthcare providers strengthen occupational exposure prevention, infection control, and procedural standardization, safety upgrades in phlebotomy have become a firm requirement. Touch-activated phlebotomy devices align with the need to reduce steps, minimize exposure, and improve consistency—especially in high-throughput settings such as emergency departments, outpatient draw stations, and centralized pre-analytical workflows. Workforce shifts and rising training costs further favor intuitive, repeatable devices that reduce dependence on individual technique. In many institutions, “safe phlebotomy” is evolving into a system-level procurement and governance theme, driving upgrades from single consumables toward integrated offerings that combine devices, compatible disposables, and service—expanding the commercial runway for suppliers with interface ecosystems and scalable delivery capabilities.
Challenges center on clinical adaptability, cost sensitivity, and compliance validation. Venous variability, insertion angle, and activation force can influence first-stick success and patient experience; the device must deliver stable performance across patient populations and departments. Any issues such as insensitive triggering, unclear blood return feedback, or connector incompatibility can increase procedure time and complaints. Phlebotomy supplies are also high-frequency and cost-sensitive, so suppliers must balance safety upgrades with tight cost control and reliable supply. In addition, products incorporating needle safety mechanisms require robust quality systems, regulatory compliance, and real-world usability validation; inadequate training or inconsistent use can blunt the intended safety benefits and undermine repurchase and adoption within the hospital.
Demand is shifting from “usable” to “controllable, traceable, and standardized.” Providers increasingly focus on the entire pre-analytical quality chain—patient identification, collection consistency, hemolysis/clotting control, sample logistics efficiency, and documentation of occupational exposure events. Therefore, touch-activated devices must not only be safe and easy to use, but also fit seamlessly into vacuum tube systems, phlebotomy carts, and specimen management workflows. Health-check centers and IVD-related service settings emphasize throughput and low error rates, favoring solutions that shorten cycle time and reduce rework. For populations with difficult venous access (pediatrics, geriatrics, oncology), the market leans toward variants with enhanced control and clear visual/functional feedback. Overall, product portfolios are evolving toward scenario-specific series and a complementary consumable ecosystem.
Key upstream inputs include medical-grade stainless-steel cannulae and bevel grinding, medical polymers for hubs/housings and activation structures, elastomers and seals for valves and leak prevention, transparent materials for observation windows, and connector components compatible with vacuum tubes or extension sets. For safety lockout and anti-rebound mechanisms, consistency of micro-springs, latches, and precision assembly determines activation feel and reliability. Because the device contacts blood directly or operates in near-blood environments, biocompatibility, sterilization compatibility, extractables/leachables control, and batch stability are critical. At scale, injection mold accuracy, automated assembly yield, and in-line inspection capabilities become decisive. Ultimately, upstream stability and quality management translate into first-stick performance, leakage risk, and safety-mechanism reliability—forming the foundation for brand trust and long-term institutional partnerships.
This report is a detailed and comprehensive analysis for global Touch Activated Phlebotomy Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Touch Activated Phlebotomy Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Touch Activated Phlebotomy Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Touch Activated Phlebotomy Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Touch Activated Phlebotomy Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Touch Activated Phlebotomy Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Touch Activated Phlebotomy Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Greiner Bio-One, Terumo, Nipro, B. Braun, Sarstedt, Cardinal Health, Medline, ICU Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Touch Activated Phlebotomy Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Peripheral Venous Phlebotomy
- Central Line Sampling Support
- Other
- Passive Safety
- Active Safet
- Passive/Auto-Engage
- User-Activated Mechanisms
- Other
- Hospitals
- Diagnostics/Reference Labs
- Other
- BD
- Greiner Bio-One
- Terumo
- Nipro
- B. Braun
- Sarstedt
- Cardinal Health
- Medline
- ICU Medical
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Touch Activated Phlebotomy Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Touch Activated Phlebotomy Device, with price, sales quantity, revenue, and global market share of Touch Activated Phlebotomy Device from 2021 to 2026.
Chapter 3, the Touch Activated Phlebotomy Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Touch Activated Phlebotomy Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Touch Activated Phlebotomy Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Touch Activated Phlebotomy Device.
Chapter 14 and 15, to describe Touch Activated Phlebotomy Device sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Touch Activated Phlebotomy Device Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Peripheral Venous Phlebotomy
1.3.3 Central Line Sampling Support
1.3.4 Other
1.4 Market Analysis by Needlestick
1.4.1 Overview: Global Touch Activated Phlebotomy Device Consumption Value by Needlestick: 2021 Versus 2025 Versus 2032
1.4.2 Passive Safety
1.4.3 Active Safet
1.5 Market Analysis by Safety Mechanism
1.5.1 Overview: Global Touch Activated Phlebotomy Device Consumption Value by Safety Mechanism: 2021 Versus 2025 Versus 2032
1.5.2 Passive/Auto-Engage
1.5.3 User-Activated Mechanisms
1.5.4 Other
1.6 Market Analysis by Application
1.6.1 Overview: Global Touch Activated Phlebotomy Device Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals
1.6.3 Diagnostics/Reference Labs
1.6.4 Other
1.7 Global Touch Activated Phlebotomy Device Market Size & Forecast
1.7.1 Global Touch Activated Phlebotomy Device Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Touch Activated Phlebotomy Device Sales Quantity (2021-2032)
1.7.3 Global Touch Activated Phlebotomy Device Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Touch Activated Phlebotomy Device Product and Services
2.1.4 BD Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 BD Recent Developments/Updates
2.2 Greiner Bio-One
2.2.1 Greiner Bio-One Details
2.2.2 Greiner Bio-One Major Business
2.2.3 Greiner Bio-One Touch Activated Phlebotomy Device Product and Services
2.2.4 Greiner Bio-One Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Greiner Bio-One Recent Developments/Updates
2.3 Terumo
2.3.1 Terumo Details
2.3.2 Terumo Major Business
2.3.3 Terumo Touch Activated Phlebotomy Device Product and Services
2.3.4 Terumo Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Terumo Recent Developments/Updates
2.4 Nipro
2.4.1 Nipro Details
2.4.2 Nipro Major Business
2.4.3 Nipro Touch Activated Phlebotomy Device Product and Services
2.4.4 Nipro Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Nipro Recent Developments/Updates
2.5 B. Braun
2.5.1 B. Braun Details
2.5.2 B. Braun Major Business
2.5.3 B. Braun Touch Activated Phlebotomy Device Product and Services
2.5.4 B. Braun Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 B. Braun Recent Developments/Updates
2.6 Sarstedt
2.6.1 Sarstedt Details
2.6.2 Sarstedt Major Business
2.6.3 Sarstedt Touch Activated Phlebotomy Device Product and Services
2.6.4 Sarstedt Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Sarstedt Recent Developments/Updates
2.7 Cardinal Health
2.7.1 Cardinal Health Details
2.7.2 Cardinal Health Major Business
2.7.3 Cardinal Health Touch Activated Phlebotomy Device Product and Services
2.7.4 Cardinal Health Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Cardinal Health Recent Developments/Updates
2.8 Medline
2.8.1 Medline Details
2.8.2 Medline Major Business
2.8.3 Medline Touch Activated Phlebotomy Device Product and Services
2.8.4 Medline Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Medline Recent Developments/Updates
2.9 ICU Medical
2.9.1 ICU Medical Details
2.9.2 ICU Medical Major Business
2.9.3 ICU Medical Touch Activated Phlebotomy Device Product and Services
2.9.4 ICU Medical Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 ICU Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TOUCH ACTIVATED PHLEBOTOMY DEVICE BY MANUFACTURER
3.1 Global Touch Activated Phlebotomy Device Sales Quantity by Manufacturer (2021-2026)
3.2 Global Touch Activated Phlebotomy Device Revenue by Manufacturer (2021-2026)
3.3 Global Touch Activated Phlebotomy Device Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Touch Activated Phlebotomy Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Touch Activated Phlebotomy Device Manufacturer Market Share in 2025
3.4.3 Top 6 Touch Activated Phlebotomy Device Manufacturer Market Share in 2025
3.5 Touch Activated Phlebotomy Device Market: Overall Company Footprint Analysis
3.5.1 Touch Activated Phlebotomy Device Market: Region Footprint
3.5.2 Touch Activated Phlebotomy Device Market: Company Product Type Footprint
3.5.3 Touch Activated Phlebotomy Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Touch Activated Phlebotomy Device Market Size by Region
4.1.1 Global Touch Activated Phlebotomy Device Sales Quantity by Region (2021-2032)
4.1.2 Global Touch Activated Phlebotomy Device Consumption Value by Region (2021-2032)
4.1.3 Global Touch Activated Phlebotomy Device Average Price by Region (2021-2032)
4.2 North America Touch Activated Phlebotomy Device Consumption Value (2021-2032)
4.3 Europe Touch Activated Phlebotomy Device Consumption Value (2021-2032)
4.4 Asia-Pacific Touch Activated Phlebotomy Device Consumption Value (2021-2032)
4.5 South America Touch Activated Phlebotomy Device Consumption Value (2021-2032)
4.6 Middle East & Africa Touch Activated Phlebotomy Device Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
5.2 Global Touch Activated Phlebotomy Device Consumption Value by Type (2021-2032)
5.3 Global Touch Activated Phlebotomy Device Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
6.2 Global Touch Activated Phlebotomy Device Consumption Value by Application (2021-2032)
6.3 Global Touch Activated Phlebotomy Device Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
7.2 North America Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
7.3 North America Touch Activated Phlebotomy Device Market Size by Country
7.3.1 North America Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2032)
7.3.2 North America Touch Activated Phlebotomy Device Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
8.2 Europe Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
8.3 Europe Touch Activated Phlebotomy Device Market Size by Country
8.3.1 Europe Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2032)
8.3.2 Europe Touch Activated Phlebotomy Device Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Touch Activated Phlebotomy Device Market Size by Region
9.3.1 Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Touch Activated Phlebotomy Device Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
10.2 South America Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
10.3 South America Touch Activated Phlebotomy Device Market Size by Country
10.3.1 South America Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2032)
10.3.2 South America Touch Activated Phlebotomy Device Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Touch Activated Phlebotomy Device Market Size by Country
11.3.1 Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Touch Activated Phlebotomy Device Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Touch Activated Phlebotomy Device Market Drivers
12.2 Touch Activated Phlebotomy Device Market Restraints
12.3 Touch Activated Phlebotomy Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Touch Activated Phlebotomy Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Touch Activated Phlebotomy Device
13.3 Touch Activated Phlebotomy Device Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Touch Activated Phlebotomy Device Typical Distributors
14.3 Touch Activated Phlebotomy Device Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Touch Activated Phlebotomy Device Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Peripheral Venous Phlebotomy
1.3.3 Central Line Sampling Support
1.3.4 Other
1.4 Market Analysis by Needlestick
1.4.1 Overview: Global Touch Activated Phlebotomy Device Consumption Value by Needlestick: 2021 Versus 2025 Versus 2032
1.4.2 Passive Safety
1.4.3 Active Safet
1.5 Market Analysis by Safety Mechanism
1.5.1 Overview: Global Touch Activated Phlebotomy Device Consumption Value by Safety Mechanism: 2021 Versus 2025 Versus 2032
1.5.2 Passive/Auto-Engage
1.5.3 User-Activated Mechanisms
1.5.4 Other
1.6 Market Analysis by Application
1.6.1 Overview: Global Touch Activated Phlebotomy Device Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals
1.6.3 Diagnostics/Reference Labs
1.6.4 Other
1.7 Global Touch Activated Phlebotomy Device Market Size & Forecast
1.7.1 Global Touch Activated Phlebotomy Device Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Touch Activated Phlebotomy Device Sales Quantity (2021-2032)
1.7.3 Global Touch Activated Phlebotomy Device Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Touch Activated Phlebotomy Device Product and Services
2.1.4 BD Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 BD Recent Developments/Updates
2.2 Greiner Bio-One
2.2.1 Greiner Bio-One Details
2.2.2 Greiner Bio-One Major Business
2.2.3 Greiner Bio-One Touch Activated Phlebotomy Device Product and Services
2.2.4 Greiner Bio-One Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Greiner Bio-One Recent Developments/Updates
2.3 Terumo
2.3.1 Terumo Details
2.3.2 Terumo Major Business
2.3.3 Terumo Touch Activated Phlebotomy Device Product and Services
2.3.4 Terumo Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Terumo Recent Developments/Updates
2.4 Nipro
2.4.1 Nipro Details
2.4.2 Nipro Major Business
2.4.3 Nipro Touch Activated Phlebotomy Device Product and Services
2.4.4 Nipro Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Nipro Recent Developments/Updates
2.5 B. Braun
2.5.1 B. Braun Details
2.5.2 B. Braun Major Business
2.5.3 B. Braun Touch Activated Phlebotomy Device Product and Services
2.5.4 B. Braun Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 B. Braun Recent Developments/Updates
2.6 Sarstedt
2.6.1 Sarstedt Details
2.6.2 Sarstedt Major Business
2.6.3 Sarstedt Touch Activated Phlebotomy Device Product and Services
2.6.4 Sarstedt Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Sarstedt Recent Developments/Updates
2.7 Cardinal Health
2.7.1 Cardinal Health Details
2.7.2 Cardinal Health Major Business
2.7.3 Cardinal Health Touch Activated Phlebotomy Device Product and Services
2.7.4 Cardinal Health Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Cardinal Health Recent Developments/Updates
2.8 Medline
2.8.1 Medline Details
2.8.2 Medline Major Business
2.8.3 Medline Touch Activated Phlebotomy Device Product and Services
2.8.4 Medline Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Medline Recent Developments/Updates
2.9 ICU Medical
2.9.1 ICU Medical Details
2.9.2 ICU Medical Major Business
2.9.3 ICU Medical Touch Activated Phlebotomy Device Product and Services
2.9.4 ICU Medical Touch Activated Phlebotomy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 ICU Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TOUCH ACTIVATED PHLEBOTOMY DEVICE BY MANUFACTURER
3.1 Global Touch Activated Phlebotomy Device Sales Quantity by Manufacturer (2021-2026)
3.2 Global Touch Activated Phlebotomy Device Revenue by Manufacturer (2021-2026)
3.3 Global Touch Activated Phlebotomy Device Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Touch Activated Phlebotomy Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Touch Activated Phlebotomy Device Manufacturer Market Share in 2025
3.4.3 Top 6 Touch Activated Phlebotomy Device Manufacturer Market Share in 2025
3.5 Touch Activated Phlebotomy Device Market: Overall Company Footprint Analysis
3.5.1 Touch Activated Phlebotomy Device Market: Region Footprint
3.5.2 Touch Activated Phlebotomy Device Market: Company Product Type Footprint
3.5.3 Touch Activated Phlebotomy Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Touch Activated Phlebotomy Device Market Size by Region
4.1.1 Global Touch Activated Phlebotomy Device Sales Quantity by Region (2021-2032)
4.1.2 Global Touch Activated Phlebotomy Device Consumption Value by Region (2021-2032)
4.1.3 Global Touch Activated Phlebotomy Device Average Price by Region (2021-2032)
4.2 North America Touch Activated Phlebotomy Device Consumption Value (2021-2032)
4.3 Europe Touch Activated Phlebotomy Device Consumption Value (2021-2032)
4.4 Asia-Pacific Touch Activated Phlebotomy Device Consumption Value (2021-2032)
4.5 South America Touch Activated Phlebotomy Device Consumption Value (2021-2032)
4.6 Middle East & Africa Touch Activated Phlebotomy Device Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
5.2 Global Touch Activated Phlebotomy Device Consumption Value by Type (2021-2032)
5.3 Global Touch Activated Phlebotomy Device Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
6.2 Global Touch Activated Phlebotomy Device Consumption Value by Application (2021-2032)
6.3 Global Touch Activated Phlebotomy Device Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
7.2 North America Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
7.3 North America Touch Activated Phlebotomy Device Market Size by Country
7.3.1 North America Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2032)
7.3.2 North America Touch Activated Phlebotomy Device Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
8.2 Europe Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
8.3 Europe Touch Activated Phlebotomy Device Market Size by Country
8.3.1 Europe Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2032)
8.3.2 Europe Touch Activated Phlebotomy Device Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Touch Activated Phlebotomy Device Market Size by Region
9.3.1 Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Touch Activated Phlebotomy Device Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
10.2 South America Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
10.3 South America Touch Activated Phlebotomy Device Market Size by Country
10.3.1 South America Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2032)
10.3.2 South America Touch Activated Phlebotomy Device Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Touch Activated Phlebotomy Device Market Size by Country
11.3.1 Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Touch Activated Phlebotomy Device Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Touch Activated Phlebotomy Device Market Drivers
12.2 Touch Activated Phlebotomy Device Market Restraints
12.3 Touch Activated Phlebotomy Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Touch Activated Phlebotomy Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Touch Activated Phlebotomy Device
13.3 Touch Activated Phlebotomy Device Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Touch Activated Phlebotomy Device Typical Distributors
14.3 Touch Activated Phlebotomy Device Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Touch Activated Phlebotomy Device Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Touch Activated Phlebotomy Device Consumption Value by Needlestick, (USD Million), 2021 & 2025 & 2032
Table 3. Global Touch Activated Phlebotomy Device Consumption Value by Safety Mechanism, (USD Million), 2021 & 2025 & 2032
Table 4. Global Touch Activated Phlebotomy Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. BD Basic Information, Manufacturing Base and Competitors
Table 6. BD Major Business
Table 7. BD Touch Activated Phlebotomy Device Product and Services
Table 8. BD Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. BD Recent Developments/Updates
Table 10. Greiner Bio-One Basic Information, Manufacturing Base and Competitors
Table 11. Greiner Bio-One Major Business
Table 12. Greiner Bio-One Touch Activated Phlebotomy Device Product and Services
Table 13. Greiner Bio-One Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Greiner Bio-One Recent Developments/Updates
Table 15. Terumo Basic Information, Manufacturing Base and Competitors
Table 16. Terumo Major Business
Table 17. Terumo Touch Activated Phlebotomy Device Product and Services
Table 18. Terumo Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Terumo Recent Developments/Updates
Table 20. Nipro Basic Information, Manufacturing Base and Competitors
Table 21. Nipro Major Business
Table 22. Nipro Touch Activated Phlebotomy Device Product and Services
Table 23. Nipro Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Nipro Recent Developments/Updates
Table 25. B. Braun Basic Information, Manufacturing Base and Competitors
Table 26. B. Braun Major Business
Table 27. B. Braun Touch Activated Phlebotomy Device Product and Services
Table 28. B. Braun Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. B. Braun Recent Developments/Updates
Table 30. Sarstedt Basic Information, Manufacturing Base and Competitors
Table 31. Sarstedt Major Business
Table 32. Sarstedt Touch Activated Phlebotomy Device Product and Services
Table 33. Sarstedt Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Sarstedt Recent Developments/Updates
Table 35. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 36. Cardinal Health Major Business
Table 37. Cardinal Health Touch Activated Phlebotomy Device Product and Services
Table 38. Cardinal Health Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Cardinal Health Recent Developments/Updates
Table 40. Medline Basic Information, Manufacturing Base and Competitors
Table 41. Medline Major Business
Table 42. Medline Touch Activated Phlebotomy Device Product and Services
Table 43. Medline Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Medline Recent Developments/Updates
Table 45. ICU Medical Basic Information, Manufacturing Base and Competitors
Table 46. ICU Medical Major Business
Table 47. ICU Medical Touch Activated Phlebotomy Device Product and Services
Table 48. ICU Medical Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. ICU Medical Recent Developments/Updates
Table 50. Global Touch Activated Phlebotomy Device Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 51. Global Touch Activated Phlebotomy Device Revenue by Manufacturer (2021-2026) & (USD Million)
Table 52. Global Touch Activated Phlebotomy Device Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 53. Market Position of Manufacturers in Touch Activated Phlebotomy Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 54. Head Office and Touch Activated Phlebotomy Device Production Site of Key Manufacturer
Table 55. Touch Activated Phlebotomy Device Market: Company Product Type Footprint
Table 56. Touch Activated Phlebotomy Device Market: Company Product Application Footprint
Table 57. Touch Activated Phlebotomy Device New Market Entrants and Barriers to Market Entry
Table 58. Touch Activated Phlebotomy Device Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Touch Activated Phlebotomy Device Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 60. Global Touch Activated Phlebotomy Device Sales Quantity by Region (2021-2026) & (K Units)
Table 61. Global Touch Activated Phlebotomy Device Sales Quantity by Region (2027-2032) & (K Units)
Table 62. Global Touch Activated Phlebotomy Device Consumption Value by Region (2021-2026) & (USD Million)
Table 63. Global Touch Activated Phlebotomy Device Consumption Value by Region (2027-2032) & (USD Million)
Table 64. Global Touch Activated Phlebotomy Device Average Price by Region (2021-2026) & (US$/Unit)
Table 65. Global Touch Activated Phlebotomy Device Average Price by Region (2027-2032) & (US$/Unit)
Table 66. Global Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 67. Global Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 68. Global Touch Activated Phlebotomy Device Consumption Value by Type (2021-2026) & (USD Million)
Table 69. Global Touch Activated Phlebotomy Device Consumption Value by Type (2027-2032) & (USD Million)
Table 70. Global Touch Activated Phlebotomy Device Average Price by Type (2021-2026) & (US$/Unit)
Table 71. Global Touch Activated Phlebotomy Device Average Price by Type (2027-2032) & (US$/Unit)
Table 72. Global Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 73. Global Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 74. Global Touch Activated Phlebotomy Device Consumption Value by Application (2021-2026) & (USD Million)
Table 75. Global Touch Activated Phlebotomy Device Consumption Value by Application (2027-2032) & (USD Million)
Table 76. Global Touch Activated Phlebotomy Device Average Price by Application (2021-2026) & (US$/Unit)
Table 77. Global Touch Activated Phlebotomy Device Average Price by Application (2027-2032) & (US$/Unit)
Table 78. North America Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 79. North America Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 80. North America Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 81. North America Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 82. North America Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2026) & (K Units)
Table 83. North America Touch Activated Phlebotomy Device Sales Quantity by Country (2027-2032) & (K Units)
Table 84. North America Touch Activated Phlebotomy Device Consumption Value by Country (2021-2026) & (USD Million)
Table 85. North America Touch Activated Phlebotomy Device Consumption Value by Country (2027-2032) & (USD Million)
Table 86. Europe Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 87. Europe Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 88. Europe Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 89. Europe Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 90. Europe Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2026) & (K Units)
Table 91. Europe Touch Activated Phlebotomy Device Sales Quantity by Country (2027-2032) & (K Units)
Table 92. Europe Touch Activated Phlebotomy Device Consumption Value by Country (2021-2026) & (USD Million)
Table 93. Europe Touch Activated Phlebotomy Device Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 95. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 96. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 97. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 98. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Region (2021-2026) & (K Units)
Table 99. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Region (2027-2032) & (K Units)
Table 100. Asia-Pacific Touch Activated Phlebotomy Device Consumption Value by Region (2021-2026) & (USD Million)
Table 101. Asia-Pacific Touch Activated Phlebotomy Device Consumption Value by Region (2027-2032) & (USD Million)
Table 102. South America Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 103. South America Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 104. South America Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 105. South America Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 106. South America Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2026) & (K Units)
Table 107. South America Touch Activated Phlebotomy Device Sales Quantity by Country (2027-2032) & (K Units)
Table 108. South America Touch Activated Phlebotomy Device Consumption Value by Country (2021-2026) & (USD Million)
Table 109. South America Touch Activated Phlebotomy Device Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 111. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 112. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 113. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 114. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2026) & (K Units)
Table 115. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Country (2027-2032) & (K Units)
Table 116. Middle East & Africa Touch Activated Phlebotomy Device Consumption Value by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Touch Activated Phlebotomy Device Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Touch Activated Phlebotomy Device Raw Material
Table 119. Key Manufacturers of Touch Activated Phlebotomy Device Raw Materials
Table 120. Touch Activated Phlebotomy Device Typical Distributors
Table 121. Touch Activated Phlebotomy Device Typical Customers
Table 1. Global Touch Activated Phlebotomy Device Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Touch Activated Phlebotomy Device Consumption Value by Needlestick, (USD Million), 2021 & 2025 & 2032
Table 3. Global Touch Activated Phlebotomy Device Consumption Value by Safety Mechanism, (USD Million), 2021 & 2025 & 2032
Table 4. Global Touch Activated Phlebotomy Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. BD Basic Information, Manufacturing Base and Competitors
Table 6. BD Major Business
Table 7. BD Touch Activated Phlebotomy Device Product and Services
Table 8. BD Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. BD Recent Developments/Updates
Table 10. Greiner Bio-One Basic Information, Manufacturing Base and Competitors
Table 11. Greiner Bio-One Major Business
Table 12. Greiner Bio-One Touch Activated Phlebotomy Device Product and Services
Table 13. Greiner Bio-One Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Greiner Bio-One Recent Developments/Updates
Table 15. Terumo Basic Information, Manufacturing Base and Competitors
Table 16. Terumo Major Business
Table 17. Terumo Touch Activated Phlebotomy Device Product and Services
Table 18. Terumo Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Terumo Recent Developments/Updates
Table 20. Nipro Basic Information, Manufacturing Base and Competitors
Table 21. Nipro Major Business
Table 22. Nipro Touch Activated Phlebotomy Device Product and Services
Table 23. Nipro Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Nipro Recent Developments/Updates
Table 25. B. Braun Basic Information, Manufacturing Base and Competitors
Table 26. B. Braun Major Business
Table 27. B. Braun Touch Activated Phlebotomy Device Product and Services
Table 28. B. Braun Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. B. Braun Recent Developments/Updates
Table 30. Sarstedt Basic Information, Manufacturing Base and Competitors
Table 31. Sarstedt Major Business
Table 32. Sarstedt Touch Activated Phlebotomy Device Product and Services
Table 33. Sarstedt Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Sarstedt Recent Developments/Updates
Table 35. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 36. Cardinal Health Major Business
Table 37. Cardinal Health Touch Activated Phlebotomy Device Product and Services
Table 38. Cardinal Health Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Cardinal Health Recent Developments/Updates
Table 40. Medline Basic Information, Manufacturing Base and Competitors
Table 41. Medline Major Business
Table 42. Medline Touch Activated Phlebotomy Device Product and Services
Table 43. Medline Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Medline Recent Developments/Updates
Table 45. ICU Medical Basic Information, Manufacturing Base and Competitors
Table 46. ICU Medical Major Business
Table 47. ICU Medical Touch Activated Phlebotomy Device Product and Services
Table 48. ICU Medical Touch Activated Phlebotomy Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. ICU Medical Recent Developments/Updates
Table 50. Global Touch Activated Phlebotomy Device Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 51. Global Touch Activated Phlebotomy Device Revenue by Manufacturer (2021-2026) & (USD Million)
Table 52. Global Touch Activated Phlebotomy Device Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 53. Market Position of Manufacturers in Touch Activated Phlebotomy Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 54. Head Office and Touch Activated Phlebotomy Device Production Site of Key Manufacturer
Table 55. Touch Activated Phlebotomy Device Market: Company Product Type Footprint
Table 56. Touch Activated Phlebotomy Device Market: Company Product Application Footprint
Table 57. Touch Activated Phlebotomy Device New Market Entrants and Barriers to Market Entry
Table 58. Touch Activated Phlebotomy Device Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Touch Activated Phlebotomy Device Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 60. Global Touch Activated Phlebotomy Device Sales Quantity by Region (2021-2026) & (K Units)
Table 61. Global Touch Activated Phlebotomy Device Sales Quantity by Region (2027-2032) & (K Units)
Table 62. Global Touch Activated Phlebotomy Device Consumption Value by Region (2021-2026) & (USD Million)
Table 63. Global Touch Activated Phlebotomy Device Consumption Value by Region (2027-2032) & (USD Million)
Table 64. Global Touch Activated Phlebotomy Device Average Price by Region (2021-2026) & (US$/Unit)
Table 65. Global Touch Activated Phlebotomy Device Average Price by Region (2027-2032) & (US$/Unit)
Table 66. Global Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 67. Global Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 68. Global Touch Activated Phlebotomy Device Consumption Value by Type (2021-2026) & (USD Million)
Table 69. Global Touch Activated Phlebotomy Device Consumption Value by Type (2027-2032) & (USD Million)
Table 70. Global Touch Activated Phlebotomy Device Average Price by Type (2021-2026) & (US$/Unit)
Table 71. Global Touch Activated Phlebotomy Device Average Price by Type (2027-2032) & (US$/Unit)
Table 72. Global Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 73. Global Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 74. Global Touch Activated Phlebotomy Device Consumption Value by Application (2021-2026) & (USD Million)
Table 75. Global Touch Activated Phlebotomy Device Consumption Value by Application (2027-2032) & (USD Million)
Table 76. Global Touch Activated Phlebotomy Device Average Price by Application (2021-2026) & (US$/Unit)
Table 77. Global Touch Activated Phlebotomy Device Average Price by Application (2027-2032) & (US$/Unit)
Table 78. North America Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 79. North America Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 80. North America Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 81. North America Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 82. North America Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2026) & (K Units)
Table 83. North America Touch Activated Phlebotomy Device Sales Quantity by Country (2027-2032) & (K Units)
Table 84. North America Touch Activated Phlebotomy Device Consumption Value by Country (2021-2026) & (USD Million)
Table 85. North America Touch Activated Phlebotomy Device Consumption Value by Country (2027-2032) & (USD Million)
Table 86. Europe Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 87. Europe Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 88. Europe Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 89. Europe Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 90. Europe Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2026) & (K Units)
Table 91. Europe Touch Activated Phlebotomy Device Sales Quantity by Country (2027-2032) & (K Units)
Table 92. Europe Touch Activated Phlebotomy Device Consumption Value by Country (2021-2026) & (USD Million)
Table 93. Europe Touch Activated Phlebotomy Device Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 95. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 96. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 97. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 98. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Region (2021-2026) & (K Units)
Table 99. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity by Region (2027-2032) & (K Units)
Table 100. Asia-Pacific Touch Activated Phlebotomy Device Consumption Value by Region (2021-2026) & (USD Million)
Table 101. Asia-Pacific Touch Activated Phlebotomy Device Consumption Value by Region (2027-2032) & (USD Million)
Table 102. South America Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 103. South America Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 104. South America Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 105. South America Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 106. South America Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2026) & (K Units)
Table 107. South America Touch Activated Phlebotomy Device Sales Quantity by Country (2027-2032) & (K Units)
Table 108. South America Touch Activated Phlebotomy Device Consumption Value by Country (2021-2026) & (USD Million)
Table 109. South America Touch Activated Phlebotomy Device Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Type (2021-2026) & (K Units)
Table 111. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Type (2027-2032) & (K Units)
Table 112. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Application (2021-2026) & (K Units)
Table 113. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Application (2027-2032) & (K Units)
Table 114. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Country (2021-2026) & (K Units)
Table 115. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity by Country (2027-2032) & (K Units)
Table 116. Middle East & Africa Touch Activated Phlebotomy Device Consumption Value by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Touch Activated Phlebotomy Device Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Touch Activated Phlebotomy Device Raw Material
Table 119. Key Manufacturers of Touch Activated Phlebotomy Device Raw Materials
Table 120. Touch Activated Phlebotomy Device Typical Distributors
Table 121. Touch Activated Phlebotomy Device Typical Customers
LIST OF FIGURES
Figure 1. Touch Activated Phlebotomy Device Picture
Figure 2. Global Touch Activated Phlebotomy Device Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Touch Activated Phlebotomy Device Revenue Market Share by Type in 2025
Figure 4. Peripheral Venous Phlebotomy Examples
Figure 5. Central Line Sampling Support Examples
Figure 6. Other Examples
Figure 7. Global Touch Activated Phlebotomy Device Revenue by Needlestick, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Touch Activated Phlebotomy Device Revenue Market Share by Needlestick in 2025
Figure 9. Passive Safety Examples
Figure 10. Active Safet Examples
Figure 11. Global Touch Activated Phlebotomy Device Revenue by Safety Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Touch Activated Phlebotomy Device Revenue Market Share by Safety Mechanism in 2025
Figure 13. Passive/Auto-Engage Examples
Figure 14. User-Activated Mechanisms Examples
Figure 15. Other Examples
Figure 16. Global Touch Activated Phlebotomy Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Touch Activated Phlebotomy Device Revenue Market Share by Application in 2025
Figure 18. Hospitals Examples
Figure 19. Diagnostics/Reference Labs Examples
Figure 20. Other Examples
Figure 21. Global Touch Activated Phlebotomy Device Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Touch Activated Phlebotomy Device Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Touch Activated Phlebotomy Device Sales Quantity (2021-2032) & (K Units)
Figure 24. Global Touch Activated Phlebotomy Device Price (2021-2032) & (US$/Unit)
Figure 25. Global Touch Activated Phlebotomy Device Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global Touch Activated Phlebotomy Device Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of Touch Activated Phlebotomy Device by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 Touch Activated Phlebotomy Device Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 Touch Activated Phlebotomy Device Manufacturer (Revenue) Market Share in 2025
Figure 30. Global Touch Activated Phlebotomy Device Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global Touch Activated Phlebotomy Device Consumption Value Market Share by Region (2021-2032)
Figure 32. North America Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 37. Global Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global Touch Activated Phlebotomy Device Consumption Value Market Share by Type (2021-2032)
Figure 39. Global Touch Activated Phlebotomy Device Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. Global Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global Touch Activated Phlebotomy Device Revenue Market Share by Application (2021-2032)
Figure 42. Global Touch Activated Phlebotomy Device Average Price by Application (2021-2032) & (US$/Unit)
Figure 43. North America Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America Touch Activated Phlebotomy Device Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America Touch Activated Phlebotomy Device Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe Touch Activated Phlebotomy Device Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe Touch Activated Phlebotomy Device Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 55. France Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific Touch Activated Phlebotomy Device Consumption Value Market Share by Region (2021-2032)
Figure 63. China Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 66. India Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America Touch Activated Phlebotomy Device Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America Touch Activated Phlebotomy Device Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa Touch Activated Phlebotomy Device Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 83. Touch Activated Phlebotomy Device Market Drivers
Figure 84. Touch Activated Phlebotomy Device Market Restraints
Figure 85. Touch Activated Phlebotomy Device Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of Touch Activated Phlebotomy Device in 2025
Figure 88. Manufacturing Process Analysis of Touch Activated Phlebotomy Device
Figure 89. Touch Activated Phlebotomy Device Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
Figure 1. Touch Activated Phlebotomy Device Picture
Figure 2. Global Touch Activated Phlebotomy Device Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Touch Activated Phlebotomy Device Revenue Market Share by Type in 2025
Figure 4. Peripheral Venous Phlebotomy Examples
Figure 5. Central Line Sampling Support Examples
Figure 6. Other Examples
Figure 7. Global Touch Activated Phlebotomy Device Revenue by Needlestick, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Touch Activated Phlebotomy Device Revenue Market Share by Needlestick in 2025
Figure 9. Passive Safety Examples
Figure 10. Active Safet Examples
Figure 11. Global Touch Activated Phlebotomy Device Revenue by Safety Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Touch Activated Phlebotomy Device Revenue Market Share by Safety Mechanism in 2025
Figure 13. Passive/Auto-Engage Examples
Figure 14. User-Activated Mechanisms Examples
Figure 15. Other Examples
Figure 16. Global Touch Activated Phlebotomy Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Touch Activated Phlebotomy Device Revenue Market Share by Application in 2025
Figure 18. Hospitals Examples
Figure 19. Diagnostics/Reference Labs Examples
Figure 20. Other Examples
Figure 21. Global Touch Activated Phlebotomy Device Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Touch Activated Phlebotomy Device Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Touch Activated Phlebotomy Device Sales Quantity (2021-2032) & (K Units)
Figure 24. Global Touch Activated Phlebotomy Device Price (2021-2032) & (US$/Unit)
Figure 25. Global Touch Activated Phlebotomy Device Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global Touch Activated Phlebotomy Device Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of Touch Activated Phlebotomy Device by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 Touch Activated Phlebotomy Device Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 Touch Activated Phlebotomy Device Manufacturer (Revenue) Market Share in 2025
Figure 30. Global Touch Activated Phlebotomy Device Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global Touch Activated Phlebotomy Device Consumption Value Market Share by Region (2021-2032)
Figure 32. North America Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 37. Global Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global Touch Activated Phlebotomy Device Consumption Value Market Share by Type (2021-2032)
Figure 39. Global Touch Activated Phlebotomy Device Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. Global Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global Touch Activated Phlebotomy Device Revenue Market Share by Application (2021-2032)
Figure 42. Global Touch Activated Phlebotomy Device Average Price by Application (2021-2032) & (US$/Unit)
Figure 43. North America Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America Touch Activated Phlebotomy Device Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America Touch Activated Phlebotomy Device Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe Touch Activated Phlebotomy Device Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe Touch Activated Phlebotomy Device Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 55. France Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Touch Activated Phlebotomy Device Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific Touch Activated Phlebotomy Device Consumption Value Market Share by Region (2021-2032)
Figure 63. China Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 66. India Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America Touch Activated Phlebotomy Device Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America Touch Activated Phlebotomy Device Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Touch Activated Phlebotomy Device Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa Touch Activated Phlebotomy Device Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa Touch Activated Phlebotomy Device Consumption Value (2021-2032) & (USD Million)
Figure 83. Touch Activated Phlebotomy Device Market Drivers
Figure 84. Touch Activated Phlebotomy Device Market Restraints
Figure 85. Touch Activated Phlebotomy Device Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of Touch Activated Phlebotomy Device in 2025
Figure 88. Manufacturing Process Analysis of Touch Activated Phlebotomy Device
Figure 89. Touch Activated Phlebotomy Device Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
